Experience of a RESPIRE3 fellow

S. Rolandsson Enes (Burlington, United States of America)

Source: International Congress 2018 – Early Career Member: career and opportunities

Session: Early Career Member: career and opportunities
Session type: Symposium
Number: 4959

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Rolandsson Enes (Burlington, United States of America). Experience of a RESPIRE3 fellow. International Congress 2018 – Early Career Member: career and opportunities

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Presentation by fellow - Speaker 6 Source: Annual Congress 2009 - Lunchtime Programme "ERS Fellows' lunch" Year: 2009
Experience in PIBO in our center Source: International Congress 2019 – Interstitial lung disease registries Year: 2019
A Combined Rheumatology/ILD Service. The Wolverhampton Experience Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases Year: 2019
Presentation by fellows of their experience and achievements Source: Annual Congress 2008 - Lunchtime programme: ERS fellows' lunch Year: 2008
Presentation by fellows of their experience and achievements Source: Annual Congress 2008 - Lunchtime programme: ERS fellows' lunch Year: 2008
Presentation by fellows of their experience and achievements Source: Annual Congress 2008 - Lunchtime programme: ERS fellows' lunch Year: 2008
Presentation by fellows of their experience and achievements Source: Annual Congress 2008 - Lunchtime programme: ERS fellows' lunch Year: 2008
Presentation by fellows of their experience and achievements Source: Annual Congress 2008 - Lunchtime programme: ERS fellows' lunch Year: 2008
Presentation by fellows of their experience and achievements Source: Annual Congress 2008 - Lunchtime programme: ERS fellows' lunch Year: 2008
Experience of olokizumab use in COVID-19 patients Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors Year: 2021